Travere Therapeutics vs Ultragenyx
Travere Therapeutics vs Ultragenyx, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Travere Therapeutics is on 51/100 and Ultragenyx on 55/100.
Where each one leads
Travere Therapeutics
Leads on none of the measures we hold for both companies.
Ultragenyx
- our overall score: 55/100 against 51/100
- agent readiness: 50/100 against 39/100
- domain rating: 67/100 against 58/100
- headcount: 1,498 against 125
- funding raised: $100M against $63.0M
At a glance
| Measure | Travere Therapeutics | Ultragenyx |
|---|---|---|
| What it is | A biopharmaceutical company focused on developing and commercializing therapies for rare diseases. | Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Rare Diseases | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2015 | 2010 |
| Headquarters | San Diego, USA | Novato, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Travere Therapeutics | Ultragenyx |
|---|---|---|
| Employees | 125 | 1,498 |
| Total funding | $63.0M | $100M |
| Latest round | Convertible Note | IPO |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 113,428 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Travere Therapeutics | Ultragenyx |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 55/100 |
| Traction | 59/100 | 60/100 |
| Team | 50/100 | 20/100 |
| Search visibility | 5/100 | 25/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 58/100 | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Travere Therapeutics | Ultragenyx |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS | Tailwind CSS |
| Analytics | Google Tag Manager, Linkedin Insight | Not detected |
| Open source | No | Yes |
Travere Therapeutics vs Ultragenyx: common questions
Which is better, Travere Therapeutics or Ultragenyx?
On our 0-100 score Ultragenyx rates higher (55/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Travere Therapeutics and Ultragenyx compare on the numbers?
Ultragenyx leads on our overall score (55/100 against 51/100), agent readiness (50/100 against 39/100), domain rating (67/100 against 58/100), headcount (1,498 against 125), funding raised ($100M against $63.0M).
Read the full Travere Therapeutics review and pricing or the Ultragenyx review and pricing. You can also browse other Travere Therapeutics alternatives we track.